Tower Research Capital (TRC)’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,039
| Closed | -$34.6K | – | 6202 |
|
|
2024
Q3 | $34.6K | Sell |
1,039
-1,744
| -63% | -$58.1K | ﹤0.01% | 2929 |
|
|
2024
Q2 | $75.2K | Buy |
2,783
+2,656
| +2,091% | +$71.8K | ﹤0.01% | 2789 |
|
|
2024
Q1 | $2.74K | Sell |
127
-1,529
| -92% | -$33K | ﹤0.01% | 4985 |
|
|
2023
Q4 | $9.99K | Sell |
1,656
-2,639
| -61% | -$15.9K | ﹤0.01% | 4313 |
|
|
2023
Q3 | $23.9K | Buy |
4,295
+3,774
| +724% | +$21K | ﹤0.01% | 3211 |
|
|
2023
Q2 | $3.82K | Sell |
521
-2,516
| -83% | -$18.5K | ﹤0.01% | 4995 |
|
|
2023
Q1 | $12K | Buy |
3,037
+236
| +8% | +$932 | ﹤0.01% | 4170 |
|
|
2022
Q4 | $9K | Sell |
2,801
-505
| -15% | -$1.62K | ﹤0.01% | 4348 |
|
|
2022
Q3 | $13K | Buy |
3,306
+160
| +5% | +$629 | ﹤0.01% | 4318 |
|
|
2022
Q2 | $10K | Buy |
3,146
+2,918
| +1,280% | +$9.28K | ﹤0.01% | 4527 |
|
|
2022
Q1 | $1K | Sell |
228
-2,558
| -92% | -$11.2K | ﹤0.01% | 6027 |
|
|
2021
Q4 | $13K | Buy |
2,786
+2,034
| +270% | +$9.49K | ﹤0.01% | 4249 |
|
|
2021
Q3 | $6K | Buy |
752
+714
| +1,879% | +$5.7K | ﹤0.01% | 4817 |
|
|
2021
Q2 | $0 | Buy |
+38
| New | – | ﹤0.01% | 6353 |
|